Nakshatri, Harikrishna <br/><br/>
Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.  [electronic resource] 

 -  Oncogene  Sep 2004 
 - 7330-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1207995  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis Regulatory Proteins<br/>Breast Neoplasms<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--physiology<br/>Female<br/>Fibroblasts--cytology<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases<br/>Membrane Glycoproteins--drug effects<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinases--drug effects<br/>NF-kappa B--deficiency<br/>Oxidative Stress--drug effects<br/>Sesquiterpenes--pharmacology<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Tumor Necrosis Factor-alpha--drug effects